Amgen Inc. (AMGN) has emerged as a standout leader within the SIA Dow Jones Industrial Average Report, strengthening throughout November despite heightened market volatility. Its rising relative strength across multiple SIA metrics highlights growing momentum within the SIA Drug Sector in general and AMGN in particular. The following analysis reviews the technical signals, support and resistance levels, and provides a brief overview of the company.
The Western Hemisphere’s energy corridor is becoming more geopolitically charged, with shifting policies, territorial tensions, and new alliances reshaping supply expectations from Venezuela to Mexico. This rising uncertainty might be contributing to a higher risk premium for the Energy sector just as SIA’s technical analytics show growing sector relative strength along with a breakout on the point and figure chart. Together, these geopolitical and technical dynamics position SIA Energy as an emerging market leader and potential defensive safe haven.
AltaGas Ltd. (ALA.TO) is gaining attention as a potential option for advisors seeking dividend-paying, lower-volatility equities in today’s uncertain market. The shares have shown improving relative strength and offers a 2.87% dividend yield. It is currently on the verge of a potential technical breakout and may be a name to watch for risk-conscious income-focused portfolios.
Shares of Eli Lilly and Company (LLY) have staged a strong comeback after dipping into the unfavored zone of the SIA S&P 100 Index Report last year, recently breaking out past $967.61 with notable technical momentum. The rally is supported by broad strength in the Drug sector and a perfect SMAX score of 10, signaling exceptional relative performance across multiple asset classes. Combined with favorable news on GLP‑1 weight-loss drug accessibility, LLY is drawing renewed attention as a leading stock in the health care sector.
As market uncertainty continues to rise, investors are shifting toward defensive names, with Consumer Staples like Loblaw Companies Ltd. gaining renewed attention. In today’s Daily Stock Report, we highlight Loblaw Companies Ltd. (L.TO) after the shares moved through a key technical breakout in Friday’s session. As of Friday’s close, the shares are at $60.51: representing a 29% price increase since our last commentary on March 17.
Brookfield Infrastructure Partners L.P. (BIP.UN.TO) is gaining attention as a potential option for advisors seeking dividend-paying, lower-volatility equities in today’s uncertain market. The utilities sector has recently moved up 12 spots in the last quarter to the favored zone at the 7th position in the SIA Sector Report, suggesting possible rotation toward more defensive, income-oriented areas. In this context, Brookfield Infrastructure has shown improving relative strength, a recent technical breakout, and offers a 4.73% dividend yield. It may be a name to watch for risk-conscious income-focused portfolios.
Today we are going to highlight Incyte Corp (INCY), which is exhibiting outperformance of late. It entered the favored zone of the SIA S&P 500 report back on August 13, 2025, at a price of $85.87. Currently the shares are at $108.16 as of yesterday’s close which represents a 25.9% increase in just under 3 months time.
The Drug sector has been on the SIA watch list for several months as a relative strength gainer. As such, today we will highlight a drug name in the Favored Zone of the SIA S&P 500 Index report. AbbVie Inc (ABBV), with a market capitalization of $383B, currently sits in the 100th out of 505 spots in SIA S&P 500 Index Report, up 141 spots in the last quarter and is up 10.28% over this trailing quarter and 19.34% over the past 6 months.
From a market and sector perspective, the Drug sector has been on the SIA watch list for several months as a relative strength gainer. While not yet a top-performing sector, certain individual stocks have shown improvement in their respective SIA matrix rankings. One such stock is Johnson & Johnson (JNJ) which we will highlight in today’s Daily Stock Report.
In today’s edition of the Daily Stock Report, we are going to look at Zscaler Inc (ZS) as a name which has exhibited strong relative performance. ZS moved into the favored zone of the SIA Nasdaq 100 Index on April 24th at a price of $210.14. As of yesterday’s close, we see the shares are at $317.92 representing a 51% increase since its favored rating and has risen 1 spot in the last week and 6 spots in the last month currently residing in the 19th spot in the Nasdaq 100 report.
Receive a daily newsletter with stock highlights, ETF rankings, weekly market focus and others.
